Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

92 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 13, 2024Nov 13 4:22 PMWELLS DAVID B
Proposed Sale
40,000$29.99$1.2M—

View →

Nov 12, 2024Nov 12 4:39 PMBoughton Soleil
Proposed Sale
2,338$26.46$61.9K—

View →

Nov 11, 2024Nov 12 1:52 PMCarroll Patrick Harrison
Proposed Sale
4,707$28.24$132.9K—

View →

Nov 11, 2024Nov 12 1:37 PMChi Michael
Proposed Sale
7,259$24.77$179.8K—

View →

Nov 5, 2024Nov 5 4:03 PMChi Michael
Proposed Sale
2,054$22.00$45.2K—

View →

Oct 29, 2024Oct 29 2:03 PMBoughton Soleil
Proposed Sale
2,339$23.16$54.2K—

View →

Oct 25, 2024Oct 25 6:00 PMChi Michael
Proposed Sale
17,304$22.00$380.7K—

View →

Oct 21, 2024Oct 21 2:59 PMChi Michael
Proposed Sale
7,500$22.20$166.5K—

View →

Oct 16, 2024Oct 16 1:58 PMBecklund Irene
Proposed Sale
471$22.64$10.7K—

View →

Oct 15, 2024Oct 15 8:19 PMChi Michael
Proposed Sale
75,493$22.00$1.7M—

View →

Oct 15, 2024Oct 15 3:43 PMBoughton Soleil
Proposed Sale
2,339$20.41$47.7K—

View →

Oct 7, 2024Oct 7 9:33 PMMelissa Baird
Proposed Sale
58,750$19.44$1.1M—

View →

Oct 1, 2024Oct 1 6:35 PMBoughton Soleil
Proposed Sale
2,339$18.50$43.3K—

View →

Sep 20, 2024Sep 20 8:34 PMAndrew Dudum
Proposed Sale
687,498$16.92$11.6M—

View →

Sep 17, 2024Sep 17 4:38 PMBoughton Soleil
Proposed Sale
2,339$16.50$38.6K—

View →

Sep 17, 2024Sep 17 2:59 PMBecklund Irene
Proposed Sale
10,017$16.50$165.3K—

View →

Sep 17, 2024Sep 17 2:57 PMChi Michael
Proposed Sale
25,550$16.50$421.6K—

View →

Sep 16, 2024Sep 16 2:53 PMBecklund Irene
Proposed Sale
472$16.45$7.8K—

View →

Sep 5, 2024Sep 5 9:22 PMMelissa Baird
Proposed Sale
11,749$14.43$169.5K—

View →

Sep 4, 2024Sep 4 10:27 PMMelissa Baird
Proposed Sale
11,749$14.61$171.7K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 13, 2026Mar 17 8:29 PMIrene BecklundPAO
Option Exercise
17,987—16,714(D)

View →

Mar 13, 2026Mar 17 8:28 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
164,369—229,805(D)

View →

Mar 13, 2026Mar 17 8:28 PMSoleil BoughtonChief Legal Officer
Option Exercise
41,421—74,194(D)

View →

Mar 13, 2026Mar 17 8:28 PMOluyemi OkupeChief Financial Officer
Option Exercise
105,200—137,790(D)

View →

Mar 11, 2026Mar 13 8:20 PMIrene BecklundPAO
Grant/Award
62,076—62,076(D)

View →

Mar 11, 2026Mar 13 8:20 PMMichael ChiChief Operating Officer
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMDeborah M. AutorDirector, Chief Policy Officer
Grant/Award
526,711—526,711(D)

View →

Mar 11, 2026Mar 13 8:20 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
150,489—150,489(D)

View →

Mar 11, 2026Mar 13 8:20 PMSoleil BoughtonChief Legal Officer
Grant/Award
188,111—188,111(D)

View →

Mar 11, 2026Mar 13 8:20 PMMohamed ElshenawyCTO
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Grant/Award
413,844—413,844(D)

View →

Mar 11, 2026Mar 13 8:20 PMOluyemi OkupeChief Financial Officer
Grant/Award
300,978—300,978(D)

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Option Exercise
5,262$5.01144,051(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,067$11.5342,996(D)

View →

← Previous

Page 4 of 4